ArticleFrontiers in pharmacology2021

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.